These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8614266)

  • 21. 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
    Winn M; von Geldern TW; Opgenorth TJ; Jae HS; Tasker AS; Boyd SA; Kester JA; Mantei RA; Bal R; Sorensen BK; Wu-Wong JR; Chiou WJ; Dixon DB; Novosad EI; Hernandez L; Marsh KC
    J Med Chem; 1996 Mar; 39(5):1039-48. PubMed ID: 8676339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Douglas SA; Edwards RM; Gellai M; Lago A; Leber JD; Cousins RD; Gao A; Frazee JS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8052-6. PubMed ID: 8058755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
    Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
    Clozel M; Breu V; Gray GA; Kalina B; Löffler BM; Burri K; Cassal JM; Hirth G; Müller M; Neidhart W
    J Pharmacol Exp Ther; 1994 Jul; 270(1):228-35. PubMed ID: 8035319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
    Maguire JJ; Kuc RE; Davenport AP
    Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cloned human endothelin receptors.
    Williams DL; Jones KL; Alves K; Chan CP; Hollis GF; Tung JS
    Life Sci; 1993; 53(5):407-14. PubMed ID: 8336519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of iris sphincter smooth muscle endothelin receptor subtypes which are coupled to cyclic AMP formation and polyphosphoinositide hydrolysis.
    el-Mowafy AM; Abdel-Latif AA
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1343-51. PubMed ID: 8138949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects.
    Chiou WJ; Wessale JL; von Geldern T; Opgenorth TJ; Wu-Wong JR
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S48-52. PubMed ID: 11078333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors.
    Maguire JJ; Kuc RE; Davenport AP
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1102-8. PubMed ID: 9023329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.
    Goldie RG; Grayson PS; Knott PG; Self GJ; Henry PJ
    Br J Pharmacol; 1994 Jul; 112(3):749-56. PubMed ID: 7921598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist.
    Reynolds EE; Keiser JA; Haleen SJ; Walker DM; Olszewski B; Schroeder RL; Taylor DG; Hwang O; Welch KM; Flynn MA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1410-7. PubMed ID: 7791115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of an endothelin ETA receptor antagonist, 50-235, and its derivatives.
    Mihara S; Sakurai K; Nakamura M; Konoike T; Fujimoto M
    Eur J Pharmacol; 1993 Oct; 247(2):219-21. PubMed ID: 8282010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
    Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
    J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of nordihydroguaiaretic acid on ETA-receptor-mediated contractions to endothelin-1 in rat trachea.
    Henry PJ
    Br J Pharmacol; 1994 Feb; 111(2):561-9. PubMed ID: 8004399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.
    Yuyama H; Sanagi M; Koakutsu A; Mori M; Fujimori A; Harada H; Sudoh K; Miyata K
    Eur J Pharmacol; 2003 Sep; 478(1):61-71. PubMed ID: 14555186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death.
    Raschack M; Unger L; Riechers H; Klinge D
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S397-9. PubMed ID: 8587425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling.
    Zhu G; Wu LH; Mauzy C; Egloff AM; Mirzadegan T; Chung FZ
    J Cell Biochem; 1992 Oct; 50(2):159-64. PubMed ID: 1429881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21).
    Urade Y; Fujitani Y; Oda K; Watakabe T; Umemura I; Takai M; Okada T; Sakata K; Karaki H
    FEBS Lett; 1992 Oct; 311(1):12-6. PubMed ID: 1397285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.